Pharma Focus Asia

Sherlock Biosciences to Open New Bio manufacturing Facility in UK


Sherlock Biosciences plans to open a new biomanufacturing facility located outside of Cambridge, UK.


This state-of-the-art facility, spanning an impressive 36,000 square feet, represents a pivotal step in enhancing Sherlock's global diagnostic capacity.

Within the campus, there resides a purpose-built manufacturing facility, spanning an impressive 36,000 square feet and holding ISO 13485 certification. 

This facility is home to class 8 clean rooms where Sherlock is presently engaged in the validation process for the production of its exclusive disposable molecular diagnostic devices, lyophilised reagent beads, and carbon particle lateral flow strips.

This facility empowers to expand its cost-effective manufacturing capabilities for their affordable, precise, and easily accessible molecular diagnostics, supporting the sustained commercial growth over the course of multiple years.


Name   Sherlock Biosciences
Type     New Construction

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024